| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print November 12, 2002
Am J Physiol Renal Physiol, 10.1152/ajprenal.00136.2002
Submitted on April 11, 2002
Accepted on November 11, 2002
1 Department of Medicine IV, University of Erlangen-Nurnberg, Erlangen, Germany
* To whom correspondence should be addressed. E-mail: karl.hilgers{at}rzmail.uni-erlangen.de.
Upregulation of the inducible cyclooxygenase (COX-2) in the macula densa accompanies the activation of the juxtaglomerular apparatus in many high-renin conditions. The functional role of COX-2 in these disease states is poorly understood. We tested whether COX-2 is required to increase renin in renovascular hypertension. Rats with established 2-kidney, 1-clip (2K1C) hypertension were treated for two weeks with two different inhibitors of COX-2, NS-398 and rofecoxib, respectively. Hypertension in 2K1C was not affected or slightly enhanced by COX-2 inhibition, as measured intraarterially in conscious animals. The increase of plasma renin activity was also unchanged by both rofecoxib and NS-398. The number of glomeruli with a renin-positive juxtaglomerular apparatus was elevated in clipped kidneys and decreased in contralateral kidneys of 2K1C. This pattern was unaltered by COX-2 inhibition. To test the effects of COX-2 blockade on an primarily macula densa-mediated stimulus, we studied salt depletion for comparison. Low-salt diet induced a significant increase of plasma renin activity, which was partially inhibited by treatment with NS-398. We conclude that inhibition of COX-2 in established renovascular hypertension does not affect renin synthesis or release. Thus, either COX-2 is not necessary for the macula densa mechanism, or the macula densa is not important for maintaining high renin in renovascular hypertension.
This article has been cited by other articles:
|
|
 |
|
  M. Araujo and W. J. Welch Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide Am J Physiol Renal Physiol, April 1, 2009; 296(4): F790 - F794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Wong, F. P. Leung, C. W. Lau, C. L. Au, L. M. Yung, X. Yao, Z.-Y. Chen, P. M. Vanhoutte, M. Gollasch, and Y. Huang Cyclooxygenase-2-Derived Prostaglandin F2{alpha} Mediates Endothelium-Dependent Contractions in the Aortae of Hamsters With Increased Impact During Aging Circ. Res., January 30, 2009; 104(2): 228 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Muller, B. Klanke, S. Feldt, N. Cordasic, A. Hartner, R. E. Schmieder, F. C. Luft, and K. F. Hilgers (Pro)Renin Receptor Peptide Inhibitor "Handle-Region" Peptide Does Not Affect Hypertensive Nephrosclerosis in Goldblatt Rats Hypertension, March 1, 2008; 51(3): 676 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Patterson, J. J. Mullins, and K. D. Mitchell Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension Am J Physiol Renal Physiol, January 1, 2008; 294(1): F205 - F211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Welch, K. Patel, P. Modlinger, M. Mendonca, N. Kawada, K. Dennehy, S. Aslam, and C. S. Wilcox Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2644 - H2649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Matzdorf, A. Kurtz, and K. Hocherl COX-2 activity determines the level of renin expression but is dispensable for acute upregulation of renin expression in rat kidneys Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1782 - F1790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Theilig, H. Debiec, B. Nafz, P. Ronco, R. Nusing, H. W. Seyberth, H. Pavenstadt, N. Bouby, and S. Bachmann Renal cortical regulation of COX-1 and functionally related products in early renovascular hypertension (rat) Am J Physiol Renal Physiol, November 1, 2006; 291(5): F987 - F994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Opay, C. R. Mouton, J. J. Mullins, and K. D. Mitchell Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension Am J Physiol Renal Physiol, September 1, 2006; 291(3): F612 - F618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Linz, K. Amann, W. Freisinger, T. Ditting, K. F. Hilgers, and R. Veelken Sensory Neurons With Afferents From Hind Limbs: Enhanced Sensitivity in Secondary Hypertension Hypertension, March 1, 2006; 47(3): 527 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Imig, X. Zhao, C. Z. Zaharis, J. J. Olearczyk, D. M. Pollock, J. W. Newman, I.-H. Kim, T. Watanabe, and B. D. Hammock An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive Hypertension Hypertension, October 1, 2005; 46(4): 975 - 981. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
